Pricing Log in Create free account

Nektar Therapeutics (NKTR) vs Tyra Biosciences, Inc. (TYRA)

Nektar Therapeutics and Tyra Biosciences, Inc. are both Biotechnology companies. Nektar Therapeutics and Tyra Biosciences, Inc. are of similar size ($1.3B and $1.3B). Tyra Biosciences, Inc. has the higher net margin (0.00% vs −287.8%) and the higher return on invested capital (0.00% vs −40.2%). Across the 13 metrics below, Tyra Biosciences, Inc. leads on 7 and Nektar Therapeutics on 6.

Valuation

Metric NKTR TYRA Biotechnology median
P/E n/m n/m 8.50
P/S 21.67 n/m 9.71
P/B 1.31 3.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 18.33 n/m 9.21
Earnings yield (18.73%) (12.96%) (33.15%)
Free cash flow yield (19.79%) (8.99%) (25.50%)

Profitability

Metric NKTR TYRA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (257.80%) 0.00% 0.00%
Net margin (287.84%) 0.00% 0.00%
Free cash flow margin (428.72%) 0.00% 0.00%
Return on equity (35.75%) (45.31%) (56.36%)
Return on assets (24.12%) (42.15%) (48.04%)
Return on invested capital (40.20%) 0.00% 0.00%

Growth

Metric NKTR TYRA Biotechnology median
Revenue growth (TTM) (27.15%) — 6.02%
EPS growth (last fiscal year) (11.89%) (33.11%) 30.26%
Revenue growth, 5-year CAGR (18.43%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NKTR TYRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.42 14.91 4.72
Net debt to EBITDA 1.77 1.94 0.96

Dividend

Metric NKTR TYRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NKTR TYRA Biotechnology median
Market cap 1.29b 1.31b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack